This photo provided by Novo Nordisk shows an injection pen of the company's drug Ozempic. On Tuesday, Dec. 5, 2017, the Food and Drug Administration approved the new, long-acting diabetes drug that reduces blood sugar levels and also helps people lose significant weight. (Novo Nordisk via AP)
Featured Photo Galleries
Trump Transition: Here are the people Trump has picked for key positions so far
President-elect Donald Trump has announced a flurry of picks for his incoming administration. Get full coverage of the Trump transition from The Washingon Times.
Trump dances onstage, takes post-election nation by storm
President-elect Trump dances onstage
